CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
61.88
+1.51 (2.50%)
At close: Mar 6, 2026, 4:00 PM EST
61.30
-0.58 (-0.94%)
After-hours: Mar 6, 2026, 7:50 PM EST
CG Oncology Market Cap
CG Oncology has a market cap or net worth of $5.22 billion as of March 6, 2026. Its market cap has increased by 143.20% in one year.
Market Cap
5.22B
Enterprise Value
4.49B
1-Year Change
143.20%
Ranking
Category
Stock Price
$61.88
Market Cap Chart
Since the IPO on January 25, 2024, CG Oncology's market cap has increased from $1.21B to $5.22B, an increase of 333.18%. That is a compound annual growth rate of 100.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 5.22B | 56.00% |
| Dec 31, 2025 | 3.35B | 53.40% |
| Dec 31, 2024 | 2.18B | 81.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CRISPR Therapeutics AG | 5.50B |
| Immunovant | 5.44B |
| Caris Life Sciences | 5.43B |
| Celcuity | 5.33B |
| Scholar Rock Holding | 5.30B |
| Mirum Pharmaceuticals | 5.30B |
| PTC Therapeutics | 5.24B |
| Apogee Therapeutics | 4.88B |